Literature DB >> 17284624

18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm.

Jung Min Kim1, Jin-Sook Ryu, Tae Yong Kim, Won Bae Kim, Gui Young Kwon, Gyungyub Gong, Dae Hyuk Moon, Seong Chul Kim, Suck Joon Hong, Young Kee Shong.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the usefulness of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in predicting malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. PATIENTS AND METHODS: A total of 46 patients with thyroid nodules larger than 1 cm in diameter cytologically diagnosed as follicular neoplasm at Asan Medical Center (Seoul, Korea) were included. FDG-PET images were taken in all patients before surgical resection, and the maximum standardized uptake value (SUVmax) of each nodule was measured.
RESULTS: FDG-PET showed hypermetabolic activity of all nodules compared with normal thyroid tissue. Thirty-six patients underwent surgery, whereas 10 refused immediate operation. Fifteen patients had cancer: 11 with follicular and two each with Hürthle cell and follicular variants of papillary cancer. Twenty-one patients had benign nodules: 11 follicular adenomas, eight adenomatous hyperplasias, and two Hürthle cell adenomas. SUVmax did not differ significantly between malignant and benign nodules (3.6 +/- 3.5 vs. 3.4 +/- 3.2; P = 0.83) or among subtypes of benign nodules (P = 0.23). However, SUVmax differed significantly among subtypes of malignant nodules (P = 0.02).
CONCLUSIONS: On FDG-PET, the glucose metabolic activities of benign thyroid follicular nodules were as high as those of malignant nodules. These findings suggest that FDG-PET has limited value for selecting candidates for surgery among patients cytologically diagnosed as follicular neoplasm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284624     DOI: 10.1210/jc.2006-2311

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results.

Authors:  Seong-Jang Kim; Samuel Chang
Journal:  Endocrine       Date:  2015-05-07       Impact factor: 3.633

2.  The final outcome of indeterminate cytology of thyroid nodules in a District General Hospital.

Authors:  S Doddi; E Chohda; S Maghsoudi; L Sheehan; A Sinha; P Chandak; P Sinha
Journal:  G Chir       Date:  2015 May-Jun

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

4.  Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.

Authors:  Amber L Traugott; Farrokh Dehdashti; Kathryn Trinkaus; Mark Cohen; Elizabeth Fialkowski; Frank Quayle; Hameda Hussain; Rosa Davila; Lourdes Ylagan; Jeffrey F Moley
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

5.  Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?

Authors:  N Muñoz Pérez; J M Villar del Moral; M A Muros Fuentes; M López de la Torre; J I Arcelus Martínez; P Becerra Massare; D Esteva Martínez; M Cañadas Garre; E Coll Del Rey; P Bueno Laraño; J A Ferrón Orihuela
Journal:  Langenbecks Arch Surg       Date:  2013-04-28       Impact factor: 3.445

Review 6.  The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.

Authors:  Brian Hung-Hin Lang; Tsz Ting Law
Journal:  Oncologist       Date:  2011-03-04

Review 7.  PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.

Authors:  Arnoldo Piccardo; Pierpaolo Trimboli; Luca Foppiani; Giorgio Treglia; Giulia Ferrarazzo; Michela Massollo; Gianluca Bottoni; Luca Giovanella
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

8.  Evaluating Focal 18F-FDG Uptake in Thyroid Gland with Radiomics.

Authors:  Ayşegül Aksu; Nazlı Pınar Karahan Şen; Emine Acar; Gamze Çapa Kaya
Journal:  Nucl Med Mol Imaging       Date:  2020-07-28

9.  PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.

Authors:  Thao T Nguyen; Natascha G E Lange; Anne L Nielsen; Anders Thomassen; Helle Døssing; Christian Godballe; Max Rohde
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-16       Impact factor: 2.503

10.  F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value.

Authors:  Francesco Bertagna; Giorgio Treglia; Arnoldo Piccardo; Elisabetta Giovannini; Giovanni Bosio; Giorgio Biasiotto; El Khayat Bahij; Roberto Maroldi; Raffaele Giubbini
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.